This article reviews current legislative and regulatory issues of importanc
e to the oncology community. Topics include patient protection, Medicare su
pport of clinical trials, research data protection, the Medical Innovation
Tax Credit, National Cancer Institute appropriations, and medical record pr
ivacy issues. Other topics discussed include funding for stem-cell research
, genetic therapy oversight, and coverage for uninsured patients.